Effect of shipment, storage, anticoagulant, and cell separation on lymphocyte proliferation assays for human immunodeficiency virus-infected patients

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 6, 1998, Pages 804-807

  Weinberg, Adriana ^a   Betensky, Rebecca A ^b   Zhang, L I ^a   Ray, Graham ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID CITRATE DEXTROSE; ANTICOAGULANT AGENT; HEPARIN; LIQUID NITROGEN;

ADULT; ANTICOAGULATION; ARTICLE; CELL SEPARATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0031742614     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.6.804-807.1998     Document Type: Article

References (11)

1. + T cell homeostasis and function in advanced HIV disease. Science 277:112-116.
2. Bindels, P. J. E., A. Krol, M. Roos, J. Veenstra, A. R. van den Hoek, F. Miedema, and R. A. Coutinho. 1995. The predictive value of T cell function in vitro and pre-AIDS zidovudine use for survival after AIDS diagnosis in a cohort orf homosexual men in Amsterdam. J. Infect. Dis. 172:97-104.
3. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat. Med. 3:533-540.
4. Fletcher, M. A., G. C. Baron, M. R. Ashman, M. A. Fischl, and N. G. Klimas. 1987. Use of whole blood methods in assessment of immune parameters in immunodeficiency states. Diagn. Clin. Immunol. 5:69-81.
5. Hammer, S. M., K. E. Squires, M. D. Hughes, J. M. Grimes, L. M. Demeter, J. S. Currier, J. J. Eron, J. E. Feinberg, H. H. Balfour, L. R. Deyton, J. A. Chodakewitz, and M. A. Fischl. 1997. A controlled study of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N. Engl. J. Med. 337:725-733.
6. Jacobson, M. A., M. Zegans, P. R. Pavan, J. J. O'Donnell, F. Sattler, N. Rao, S. Owens, and R. Pollard. 1997. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 349:1443-1445.
7. Kellehrer, A. D., A. Carr, J. Zaunders, and D. A. Cooper. 1996. Alterations in the immune response of human immunodeficiency virus-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J. Infect. Dis. 173:321-329.
8. Levin, M. J., M. Murray, G. O. Zerbe, C. J. White, and A. R. Hayward. 1994. Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine. J. Infect. Dis. 170:522-526.
9. Liang, K.-Y., and S. L. Zeger. 1986. Longitudinal data analysis using generalized linear models. Biometrika 73:13-22.
10. Neuhaus, J. M., and M-L. Lesperance. 1996. Estimation efficiency in a binary mixed-effects model setting. Biometrika 83:441-449.
11. Weinberg, A., T. Y. Basham, and T. C. Merigan. 1987. Regulation of the guinea pig immune function by interleukin-2: critical role of natural killer activity in acute HSV-2 genital infection. J. Immunol. 137:3310-3316.